nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—SLC22A2—Progesterone—uterine cancer	0.167	0.202	CbGbCtD
Diphenhydramine—SLC22A1—Progesterone—uterine cancer	0.145	0.176	CbGbCtD
Diphenhydramine—SLC22A5—Dactinomycin—uterine cancer	0.139	0.168	CbGbCtD
Diphenhydramine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0692	0.0836	CbGbCtD
Diphenhydramine—CYP2C19—Progesterone—uterine cancer	0.0551	0.0666	CbGbCtD
Diphenhydramine—PTGS1—Etoposide—uterine cancer	0.051	0.0616	CbGbCtD
Diphenhydramine—CYP1A2—Progesterone—uterine cancer	0.0509	0.0615	CbGbCtD
Diphenhydramine—CYP2C9—Progesterone—uterine cancer	0.0458	0.0554	CbGbCtD
Diphenhydramine—CYP2D6—Progesterone—uterine cancer	0.0419	0.0507	CbGbCtD
Diphenhydramine—CYP2B6—Doxorubicin—uterine cancer	0.0265	0.032	CbGbCtD
Diphenhydramine—CYP1A2—Etoposide—uterine cancer	0.0228	0.0275	CbGbCtD
Diphenhydramine—CYP2D6—Doxorubicin—uterine cancer	0.0128	0.0155	CbGbCtD
Diphenhydramine—Neuritis—Progesterone—uterine cancer	0.00328	0.0268	CcSEcCtD
Diphenhydramine—Neuritis—Medroxyprogesterone Acetate—uterine cancer	0.00297	0.0242	CcSEcCtD
Diphenhydramine—PTGS1—oviduct—uterine cancer	0.00275	0.0719	CbGeAlD
Diphenhydramine—CYP2C18—uterine cervix—uterine cancer	0.00228	0.0595	CbGeAlD
Diphenhydramine—CYP2C18—mammalian vulva—uterine cancer	0.00199	0.0521	CbGeAlD
Diphenhydramine—Nasal congestion—Progesterone—uterine cancer	0.00195	0.0159	CcSEcCtD
Diphenhydramine—Euphoric mood—Medroxyprogesterone Acetate—uterine cancer	0.00191	0.0156	CcSEcCtD
Diphenhydramine—PTGS1—artery—uterine cancer	0.00182	0.0476	CbGeAlD
Diphenhydramine—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00178	0.0146	CcSEcCtD
Diphenhydramine—Diplopia—Progesterone—uterine cancer	0.00178	0.0145	CcSEcCtD
Diphenhydramine—Irritability—Progesterone—uterine cancer	0.0017	0.0138	CcSEcCtD
Diphenhydramine—SLC22A2—renal system—uterine cancer	0.00166	0.0435	CbGeAlD
Diphenhydramine—CYP2C18—vagina—uterine cancer	0.00154	0.0403	CbGeAlD
Diphenhydramine—Irritability—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.0125	CcSEcCtD
Diphenhydramine—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.0125	CcSEcCtD
Diphenhydramine—Sweating increased—Progesterone—uterine cancer	0.0015	0.0122	CcSEcCtD
Diphenhydramine—Dysuria—Progesterone—uterine cancer	0.00144	0.0117	CcSEcCtD
Diphenhydramine—Pollakiuria—Progesterone—uterine cancer	0.00142	0.0116	CcSEcCtD
Diphenhydramine—Chest discomfort—Etoposide—uterine cancer	0.00142	0.0115	CcSEcCtD
Diphenhydramine—Drowsiness—Progesterone—uterine cancer	0.00137	0.0112	CcSEcCtD
Diphenhydramine—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.0111	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Progesterone—uterine cancer	0.00134	0.011	CcSEcCtD
Diphenhydramine—Dysuria—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.0106	CcSEcCtD
Diphenhydramine—Pollakiuria—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.0105	CcSEcCtD
Diphenhydramine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.0101	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.00993	CcSEcCtD
Diphenhydramine—Clomifene—CYP11A1—uterine cancer	0.00119	0.22	CrCbGaD
Diphenhydramine—SLC22A1—renal system—uterine cancer	0.00117	0.0307	CbGeAlD
Diphenhydramine—Tinnitus—Progesterone—uterine cancer	0.00115	0.00935	CcSEcCtD
Diphenhydramine—SLC22A5—myometrium—uterine cancer	0.00112	0.0293	CbGeAlD
Diphenhydramine—Tension—Progesterone—uterine cancer	0.00105	0.00857	CcSEcCtD
Diphenhydramine—Nervousness—Progesterone—uterine cancer	0.00104	0.00848	CcSEcCtD
Diphenhydramine—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00848	CcSEcCtD
Diphenhydramine—Vision blurred—Progesterone—uterine cancer	0.00101	0.00823	CcSEcCtD
Diphenhydramine—Tremor—Progesterone—uterine cancer	0.001	0.00818	CcSEcCtD
Diphenhydramine—Chills—Medroxyprogesterone Acetate—uterine cancer	0.000999	0.00816	CcSEcCtD
Diphenhydramine—Vertigo—Progesterone—uterine cancer	0.000961	0.00785	CcSEcCtD
Diphenhydramine—Tension—Medroxyprogesterone Acetate—uterine cancer	0.000952	0.00776	CcSEcCtD
Diphenhydramine—HRH1—myometrium—uterine cancer	0.000951	0.0249	CbGeAlD
Diphenhydramine—Palpitations—Progesterone—uterine cancer	0.000946	0.00772	CcSEcCtD
Diphenhydramine—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.000942	0.00769	CcSEcCtD
Diphenhydramine—Neuritis—Epirubicin—uterine cancer	0.00094	0.00767	CcSEcCtD
Diphenhydramine—Convulsion—Progesterone—uterine cancer	0.000927	0.00757	CcSEcCtD
Diphenhydramine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.000908	0.00741	CcSEcCtD
Diphenhydramine—Agranulocytosis—Dactinomycin—uterine cancer	0.000903	0.00737	CcSEcCtD
Diphenhydramine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.000891	0.00727	CcSEcCtD
Diphenhydramine—Dry mouth—Progesterone—uterine cancer	0.000891	0.00727	CcSEcCtD
Diphenhydramine—Confusional state—Progesterone—uterine cancer	0.000881	0.00719	CcSEcCtD
Diphenhydramine—SLC22A5—uterine cervix—uterine cancer	0.000873	0.0228	CbGeAlD
Diphenhydramine—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.000871	0.00711	CcSEcCtD
Diphenhydramine—Neuritis—Doxorubicin—uterine cancer	0.00087	0.0071	CcSEcCtD
Diphenhydramine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.000857	0.00699	CcSEcCtD
Diphenhydramine—Tachycardia—Progesterone—uterine cancer	0.000852	0.00696	CcSEcCtD
Diphenhydramine—SLC22A1—vagina—uterine cancer	0.000851	0.0222	CbGeAlD
Diphenhydramine—Hyperhidrosis—Progesterone—uterine cancer	0.000844	0.00689	CcSEcCtD
Diphenhydramine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00084	0.00686	CcSEcCtD
Diphenhydramine—Anorexia—Progesterone—uterine cancer	0.000832	0.00679	CcSEcCtD
Diphenhydramine—SLC22A5—renal system—uterine cancer	0.000816	0.0213	CbGeAlD
Diphenhydramine—Hypotension—Progesterone—uterine cancer	0.000816	0.00666	CcSEcCtD
Diphenhydramine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000807	0.00659	CcSEcCtD
Diphenhydramine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000798	0.00651	CcSEcCtD
Diphenhydramine—Insomnia—Progesterone—uterine cancer	0.00079	0.00645	CcSEcCtD
Diphenhydramine—SLC22A5—endometrium—uterine cancer	0.000789	0.0206	CbGeAlD
Diphenhydramine—Paraesthesia—Progesterone—uterine cancer	0.000784	0.0064	CcSEcCtD
Diphenhydramine—Chills—Dactinomycin—uterine cancer	0.00078	0.00636	CcSEcCtD
Diphenhydramine—Somnolence—Progesterone—uterine cancer	0.000776	0.00634	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000775	0.00632	CcSEcCtD
Diphenhydramine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000772	0.0063	CcSEcCtD
Diphenhydramine—Dyspepsia—Progesterone—uterine cancer	0.000769	0.00627	CcSEcCtD
Diphenhydramine—Sweating increased—Etoposide—uterine cancer	0.000765	0.00624	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000765	0.00624	CcSEcCtD
Diphenhydramine—Decreased appetite—Progesterone—uterine cancer	0.000759	0.0062	CcSEcCtD
Diphenhydramine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000754	0.00616	CcSEcCtD
Diphenhydramine—Fatigue—Progesterone—uterine cancer	0.000753	0.00614	CcSEcCtD
Diphenhydramine—Constipation—Progesterone—uterine cancer	0.000747	0.00609	CcSEcCtD
Diphenhydramine—HRH1—epithelium—uterine cancer	0.000746	0.0195	CbGeAlD
Diphenhydramine—HRH1—uterine cervix—uterine cancer	0.00074	0.0193	CbGeAlD
Diphenhydramine—CYP1A2—renal system—uterine cancer	0.00074	0.0193	CbGeAlD
Diphenhydramine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000739	0.00603	CcSEcCtD
Diphenhydramine—Feeling abnormal—Progesterone—uterine cancer	0.00072	0.00587	CcSEcCtD
Diphenhydramine—HRH1—smooth muscle tissue—uterine cancer	0.000719	0.0188	CbGeAlD
Diphenhydramine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000716	0.00584	CcSEcCtD
Diphenhydramine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000711	0.0058	CcSEcCtD
Diphenhydramine—CYP2B6—renal system—uterine cancer	0.000709	0.0185	CbGeAlD
Diphenhydramine—HRH1—decidua—uterine cancer	0.000705	0.0184	CbGeAlD
Diphenhydramine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000704	0.00574	CcSEcCtD
Diphenhydramine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000697	0.00568	CcSEcCtD
Diphenhydramine—Urticaria—Progesterone—uterine cancer	0.000694	0.00566	CcSEcCtD
Diphenhydramine—PTGS1—epithelium—uterine cancer	0.000691	0.0181	CbGeAlD
Diphenhydramine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000688	0.00561	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Etoposide—uterine cancer	0.000687	0.0056	CcSEcCtD
Diphenhydramine—PTGS1—uterine cervix—uterine cancer	0.000685	0.0179	CbGeAlD
Diphenhydramine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000682	0.00557	CcSEcCtD
Diphenhydramine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000677	0.00552	CcSEcCtD
Diphenhydramine—HRH1—endometrium—uterine cancer	0.000669	0.0175	CbGeAlD
Diphenhydramine—PTGS1—smooth muscle tissue—uterine cancer	0.000666	0.0174	CbGeAlD
Diphenhydramine—CYP2C19—vagina—uterine cancer	0.000656	0.0171	CbGeAlD
Diphenhydramine—Toremifene—ESR1—uterine cancer	0.000656	0.121	CrCbGaD
Diphenhydramine—SLC22A5—female reproductive system—uterine cancer	0.000654	0.0171	CbGeAlD
Diphenhydramine—Agranulocytosis—Etoposide—uterine cancer	0.000654	0.00533	CcSEcCtD
Diphenhydramine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000652	0.00532	CcSEcCtD
Diphenhydramine—HRH1—mammalian vulva—uterine cancer	0.000647	0.0169	CbGeAlD
Diphenhydramine—PTGS1—renal system—uterine cancer	0.000641	0.0168	CbGeAlD
Diphenhydramine—Bifonazole—CYP19A1—uterine cancer	0.00064	0.118	CrCbGaD
Diphenhydramine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000629	0.00513	CcSEcCtD
Diphenhydramine—Asthenia—Progesterone—uterine cancer	0.000627	0.00511	CcSEcCtD
Diphenhydramine—PTGS1—endometrium—uterine cancer	0.00062	0.0162	CbGeAlD
Diphenhydramine—Clomifene—CYP19A1—uterine cancer	0.000616	0.114	CrCbGaD
Diphenhydramine—Thrombocytopenia—Dactinomycin—uterine cancer	0.000604	0.00493	CcSEcCtD
Diphenhydramine—PTGS1—mammalian vulva—uterine cancer	0.000599	0.0157	CbGeAlD
Diphenhydramine—Diarrhoea—Progesterone—uterine cancer	0.000598	0.00488	CcSEcCtD
Diphenhydramine—SLC22A5—female gonad—uterine cancer	0.000595	0.0156	CbGeAlD
Diphenhydramine—SLC22A5—vagina—uterine cancer	0.000591	0.0155	CbGeAlD
Diphenhydramine—Anorexia—Dactinomycin—uterine cancer	0.000588	0.0048	CcSEcCtD
Diphenhydramine—Photosensitivity—Epirubicin—uterine cancer	0.00058	0.00474	CcSEcCtD
Diphenhydramine—Dizziness—Progesterone—uterine cancer	0.000578	0.00471	CcSEcCtD
Diphenhydramine—PTGS1—uterus—uterine cancer	0.000571	0.0149	CbGeAlD
Diphenhydramine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000568	0.00463	CcSEcCtD
Diphenhydramine—CYP2B6—female reproductive system—uterine cancer	0.000568	0.0148	CbGeAlD
Diphenhydramine—Clomifene—ESR1—uterine cancer	0.000567	0.105	CrCbGaD
Diphenhydramine—Chills—Etoposide—uterine cancer	0.000564	0.0046	CcSEcCtD
Diphenhydramine—CYP2C9—female reproductive system—uterine cancer	0.000562	0.0147	CbGeAlD
Diphenhydramine—Vomiting—Progesterone—uterine cancer	0.000555	0.00453	CcSEcCtD
Diphenhydramine—HRH1—female reproductive system—uterine cancer	0.000554	0.0145	CbGeAlD
Diphenhydramine—Rash—Progesterone—uterine cancer	0.000551	0.00449	CcSEcCtD
Diphenhydramine—Dermatitis—Progesterone—uterine cancer	0.00055	0.00449	CcSEcCtD
Diphenhydramine—Headache—Progesterone—uterine cancer	0.000547	0.00446	CcSEcCtD
Diphenhydramine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000541	0.00442	CcSEcCtD
Diphenhydramine—Photosensitivity—Doxorubicin—uterine cancer	0.000537	0.00438	CcSEcCtD
Diphenhydramine—Decreased appetite—Dactinomycin—uterine cancer	0.000537	0.00438	CcSEcCtD
Diphenhydramine—Fatigue—Dactinomycin—uterine cancer	0.000532	0.00434	CcSEcCtD
Diphenhydramine—CYP2D6—renal system—uterine cancer	0.000527	0.0138	CbGeAlD
Diphenhydramine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000523	0.00427	CcSEcCtD
Diphenhydramine—Nausea—Progesterone—uterine cancer	0.000519	0.00423	CcSEcCtD
Diphenhydramine—CYP2B6—vagina—uterine cancer	0.000513	0.0134	CbGeAlD
Diphenhydramine—PTGS1—female reproductive system—uterine cancer	0.000513	0.0134	CbGeAlD
Diphenhydramine—Diplopia—Epirubicin—uterine cancer	0.00051	0.00416	CcSEcCtD
Diphenhydramine—Feeling abnormal—Dactinomycin—uterine cancer	0.000509	0.00415	CcSEcCtD
Diphenhydramine—HRH1—female gonad—uterine cancer	0.000504	0.0132	CbGeAlD
Diphenhydramine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000503	0.00411	CcSEcCtD
Diphenhydramine—HRH1—vagina—uterine cancer	0.000501	0.0131	CbGeAlD
Diphenhydramine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000499	0.00407	CcSEcCtD
Diphenhydramine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000499	0.00407	CcSEcCtD
Diphenhydramine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000496	0.00405	CcSEcCtD
Diphenhydramine—Vertigo—Etoposide—uterine cancer	0.000492	0.00401	CcSEcCtD
Diphenhydramine—Levomethadyl Acetate—CYP19A1—uterine cancer	0.000481	0.089	CrCbGaD
Diphenhydramine—Convulsion—Etoposide—uterine cancer	0.000474	0.00387	CcSEcCtD
Diphenhydramine—Diplopia—Doxorubicin—uterine cancer	0.000471	0.00385	CcSEcCtD
Diphenhydramine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00047	0.00384	CcSEcCtD
Diphenhydramine—PTGS1—female gonad—uterine cancer	0.000467	0.0122	CbGeAlD
Diphenhydramine—PTGS1—vagina—uterine cancer	0.000464	0.0121	CbGeAlD
Diphenhydramine—Confusional state—Etoposide—uterine cancer	0.00045	0.00368	CcSEcCtD
Diphenhydramine—Asthenia—Dactinomycin—uterine cancer	0.000443	0.00361	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Etoposide—uterine cancer	0.000437	0.00357	CcSEcCtD
Diphenhydramine—Tachycardia—Etoposide—uterine cancer	0.000436	0.00356	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Etoposide—uterine cancer	0.000432	0.00352	CcSEcCtD
Diphenhydramine—Anorexia—Etoposide—uterine cancer	0.000426	0.00348	CcSEcCtD
Diphenhydramine—Tamoxifen—ESR2—uterine cancer	0.000425	0.0786	CrCbGaD
Diphenhydramine—Diarrhoea—Dactinomycin—uterine cancer	0.000422	0.00345	CcSEcCtD
Diphenhydramine—CYP2D6—female reproductive system—uterine cancer	0.000422	0.011	CbGeAlD
Diphenhydramine—Hypotension—Etoposide—uterine cancer	0.000417	0.00341	CcSEcCtD
Diphenhydramine—Dysuria—Epirubicin—uterine cancer	0.000412	0.00336	CcSEcCtD
Diphenhydramine—Pollakiuria—Epirubicin—uterine cancer	0.000407	0.00332	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Epirubicin—uterine cancer	0.000402	0.00328	CcSEcCtD
Diphenhydramine—Paraesthesia—Etoposide—uterine cancer	0.000401	0.00327	CcSEcCtD
Diphenhydramine—Somnolence—Etoposide—uterine cancer	0.000397	0.00324	CcSEcCtD
Diphenhydramine—Drowsiness—Epirubicin—uterine cancer	0.000393	0.0032	CcSEcCtD
Diphenhydramine—Vomiting—Dactinomycin—uterine cancer	0.000392	0.0032	CcSEcCtD
Diphenhydramine—Rash—Dactinomycin—uterine cancer	0.000389	0.00318	CcSEcCtD
Diphenhydramine—Decreased appetite—Etoposide—uterine cancer	0.000388	0.00317	CcSEcCtD
Diphenhydramine—Fatigue—Etoposide—uterine cancer	0.000385	0.00314	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Epirubicin—uterine cancer	0.000385	0.00314	CcSEcCtD
Diphenhydramine—CYP2D6—female gonad—uterine cancer	0.000384	0.01	CbGeAlD
Diphenhydramine—SLC22A5—lymph node—uterine cancer	0.000382	0.01	CbGeAlD
Diphenhydramine—Constipation—Etoposide—uterine cancer	0.000382	0.00312	CcSEcCtD
Diphenhydramine—Dysuria—Doxorubicin—uterine cancer	0.000381	0.00311	CcSEcCtD
Diphenhydramine—Pollakiuria—Doxorubicin—uterine cancer	0.000376	0.00307	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000372	0.00304	CcSEcCtD
Diphenhydramine—Feeling abnormal—Etoposide—uterine cancer	0.000368	0.003	CcSEcCtD
Diphenhydramine—Nausea—Dactinomycin—uterine cancer	0.000367	0.00299	CcSEcCtD
Diphenhydramine—Agranulocytosis—Epirubicin—uterine cancer	0.000366	0.00299	CcSEcCtD
Diphenhydramine—Drowsiness—Doxorubicin—uterine cancer	0.000363	0.00296	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000356	0.00291	CcSEcCtD
Diphenhydramine—Urticaria—Etoposide—uterine cancer	0.000355	0.0029	CcSEcCtD
Diphenhydramine—Agranulocytosis—Doxorubicin—uterine cancer	0.000339	0.00277	CcSEcCtD
Diphenhydramine—Tinnitus—Epirubicin—uterine cancer	0.000329	0.00268	CcSEcCtD
Diphenhydramine—HRH1—lymph node—uterine cancer	0.000324	0.00848	CbGeAlD
Diphenhydramine—Asthenia—Etoposide—uterine cancer	0.000321	0.00262	CcSEcCtD
Diphenhydramine—Chills—Epirubicin—uterine cancer	0.000316	0.00258	CcSEcCtD
Diphenhydramine—Diarrhoea—Etoposide—uterine cancer	0.000306	0.00249	CcSEcCtD
Diphenhydramine—Tinnitus—Doxorubicin—uterine cancer	0.000304	0.00248	CcSEcCtD
Diphenhydramine—Tension—Epirubicin—uterine cancer	0.000301	0.00246	CcSEcCtD
Diphenhydramine—PTGS1—lymph node—uterine cancer	0.0003	0.00785	CbGeAlD
Diphenhydramine—Nervousness—Epirubicin—uterine cancer	0.000298	0.00243	CcSEcCtD
Diphenhydramine—Dizziness—Etoposide—uterine cancer	0.000295	0.00241	CcSEcCtD
Diphenhydramine—Chills—Doxorubicin—uterine cancer	0.000293	0.00239	CcSEcCtD
Diphenhydramine—Vision blurred—Epirubicin—uterine cancer	0.000289	0.00236	CcSEcCtD
Diphenhydramine—Tamoxifen—CYP19A1—uterine cancer	0.000285	0.0527	CrCbGaD
Diphenhydramine—Vomiting—Etoposide—uterine cancer	0.000284	0.00232	CcSEcCtD
Diphenhydramine—Methadone—CYP19A1—uterine cancer	0.000282	0.0522	CrCbGaD
Diphenhydramine—Agitation—Epirubicin—uterine cancer	0.000282	0.0023	CcSEcCtD
Diphenhydramine—Rash—Etoposide—uterine cancer	0.000282	0.0023	CcSEcCtD
Diphenhydramine—Dermatitis—Etoposide—uterine cancer	0.000281	0.0023	CcSEcCtD
Diphenhydramine—Headache—Etoposide—uterine cancer	0.00028	0.00228	CcSEcCtD
Diphenhydramine—Tension—Doxorubicin—uterine cancer	0.000279	0.00227	CcSEcCtD
Diphenhydramine—Nervousness—Doxorubicin—uterine cancer	0.000276	0.00225	CcSEcCtD
Diphenhydramine—Vertigo—Epirubicin—uterine cancer	0.000276	0.00225	CcSEcCtD
Diphenhydramine—Palpitations—Epirubicin—uterine cancer	0.000271	0.00221	CcSEcCtD
Diphenhydramine—Vision blurred—Doxorubicin—uterine cancer	0.000268	0.00218	CcSEcCtD
Diphenhydramine—Convulsion—Epirubicin—uterine cancer	0.000266	0.00217	CcSEcCtD
Diphenhydramine—Nausea—Etoposide—uterine cancer	0.000265	0.00217	CcSEcCtD
Diphenhydramine—Tamoxifen—ESR1—uterine cancer	0.000262	0.0485	CrCbGaD
Diphenhydramine—Agitation—Doxorubicin—uterine cancer	0.000261	0.00213	CcSEcCtD
Diphenhydramine—Dry mouth—Epirubicin—uterine cancer	0.000255	0.00208	CcSEcCtD
Diphenhydramine—Vertigo—Doxorubicin—uterine cancer	0.000255	0.00208	CcSEcCtD
Diphenhydramine—Confusional state—Epirubicin—uterine cancer	0.000253	0.00206	CcSEcCtD
Diphenhydramine—Palpitations—Doxorubicin—uterine cancer	0.000251	0.00205	CcSEcCtD
Diphenhydramine—Convulsion—Doxorubicin—uterine cancer	0.000246	0.00201	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Epirubicin—uterine cancer	0.000245	0.002	CcSEcCtD
Diphenhydramine—Tachycardia—Epirubicin—uterine cancer	0.000244	0.00199	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Epirubicin—uterine cancer	0.000242	0.00198	CcSEcCtD
Diphenhydramine—Anorexia—Epirubicin—uterine cancer	0.000239	0.00195	CcSEcCtD
Diphenhydramine—Dry mouth—Doxorubicin—uterine cancer	0.000236	0.00193	CcSEcCtD
Diphenhydramine—Hypotension—Epirubicin—uterine cancer	0.000234	0.00191	CcSEcCtD
Diphenhydramine—Confusional state—Doxorubicin—uterine cancer	0.000234	0.00191	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000227	0.00185	CcSEcCtD
Diphenhydramine—Insomnia—Epirubicin—uterine cancer	0.000226	0.00185	CcSEcCtD
Diphenhydramine—Tachycardia—Doxorubicin—uterine cancer	0.000226	0.00185	CcSEcCtD
Diphenhydramine—Paraesthesia—Epirubicin—uterine cancer	0.000225	0.00184	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000224	0.00183	CcSEcCtD
Diphenhydramine—Somnolence—Epirubicin—uterine cancer	0.000223	0.00182	CcSEcCtD
Diphenhydramine—Anorexia—Doxorubicin—uterine cancer	0.000221	0.0018	CcSEcCtD
Diphenhydramine—Dyspepsia—Epirubicin—uterine cancer	0.00022	0.0018	CcSEcCtD
Diphenhydramine—Decreased appetite—Epirubicin—uterine cancer	0.000218	0.00178	CcSEcCtD
Diphenhydramine—Hypotension—Doxorubicin—uterine cancer	0.000217	0.00177	CcSEcCtD
Diphenhydramine—Fatigue—Epirubicin—uterine cancer	0.000216	0.00176	CcSEcCtD
Diphenhydramine—Constipation—Epirubicin—uterine cancer	0.000214	0.00175	CcSEcCtD
Diphenhydramine—Insomnia—Doxorubicin—uterine cancer	0.00021	0.00171	CcSEcCtD
Diphenhydramine—Paraesthesia—Doxorubicin—uterine cancer	0.000208	0.0017	CcSEcCtD
Diphenhydramine—Feeling abnormal—Epirubicin—uterine cancer	0.000206	0.00168	CcSEcCtD
Diphenhydramine—Somnolence—Doxorubicin—uterine cancer	0.000206	0.00168	CcSEcCtD
Diphenhydramine—Dyspepsia—Doxorubicin—uterine cancer	0.000204	0.00166	CcSEcCtD
Diphenhydramine—Decreased appetite—Doxorubicin—uterine cancer	0.000201	0.00164	CcSEcCtD
Diphenhydramine—Fatigue—Doxorubicin—uterine cancer	0.0002	0.00163	CcSEcCtD
Diphenhydramine—Urticaria—Epirubicin—uterine cancer	0.000199	0.00162	CcSEcCtD
Diphenhydramine—Constipation—Doxorubicin—uterine cancer	0.000198	0.00162	CcSEcCtD
Diphenhydramine—Feeling abnormal—Doxorubicin—uterine cancer	0.000191	0.00156	CcSEcCtD
Diphenhydramine—Urticaria—Doxorubicin—uterine cancer	0.000184	0.0015	CcSEcCtD
Diphenhydramine—Asthenia—Epirubicin—uterine cancer	0.00018	0.00147	CcSEcCtD
Diphenhydramine—Diarrhoea—Epirubicin—uterine cancer	0.000171	0.0014	CcSEcCtD
Diphenhydramine—Asthenia—Doxorubicin—uterine cancer	0.000166	0.00136	CcSEcCtD
Diphenhydramine—Dizziness—Epirubicin—uterine cancer	0.000166	0.00135	CcSEcCtD
Diphenhydramine—Vomiting—Epirubicin—uterine cancer	0.000159	0.0013	CcSEcCtD
Diphenhydramine—Diarrhoea—Doxorubicin—uterine cancer	0.000159	0.00129	CcSEcCtD
Diphenhydramine—Rash—Epirubicin—uterine cancer	0.000158	0.00129	CcSEcCtD
Diphenhydramine—Dermatitis—Epirubicin—uterine cancer	0.000158	0.00129	CcSEcCtD
Diphenhydramine—Headache—Epirubicin—uterine cancer	0.000157	0.00128	CcSEcCtD
Diphenhydramine—Dizziness—Doxorubicin—uterine cancer	0.000153	0.00125	CcSEcCtD
Diphenhydramine—Nausea—Epirubicin—uterine cancer	0.000149	0.00121	CcSEcCtD
Diphenhydramine—Vomiting—Doxorubicin—uterine cancer	0.000147	0.0012	CcSEcCtD
Diphenhydramine—Rash—Doxorubicin—uterine cancer	0.000146	0.00119	CcSEcCtD
Diphenhydramine—Dermatitis—Doxorubicin—uterine cancer	0.000146	0.00119	CcSEcCtD
Diphenhydramine—Headache—Doxorubicin—uterine cancer	0.000145	0.00118	CcSEcCtD
Diphenhydramine—Nausea—Doxorubicin—uterine cancer	0.000138	0.00112	CcSEcCtD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	8.21e-06	0.00127	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	7.93e-06	0.00123	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	7.8e-06	0.00121	CbGpPWpGaD
Diphenhydramine—CHRM2—G alpha (i) signalling events—CXCL8—uterine cancer	7.76e-06	0.0012	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—KRAS—uterine cancer	7.71e-06	0.0012	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—POLD1—uterine cancer	7.66e-06	0.00119	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKR1B10—uterine cancer	7.61e-06	0.00118	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—NDUFB11—uterine cancer	7.56e-06	0.00117	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—SRD5A2—uterine cancer	7.56e-06	0.00117	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKR1B10—uterine cancer	7.49e-06	0.00116	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—POLD1—uterine cancer	7.44e-06	0.00115	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	7.34e-06	0.00114	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AKR1B1—uterine cancer	7.23e-06	0.00112	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—STAR—uterine cancer	7.23e-06	0.00112	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—AKR1C1—uterine cancer	7.16e-06	0.00111	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—POLD1—uterine cancer	7.14e-06	0.00111	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—uterine cancer	7.09e-06	0.0011	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	7.02e-06	0.00109	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—AKR1C1—uterine cancer	6.96e-06	0.00108	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—NDUFB11—uterine cancer	6.95e-06	0.00108	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SRD5A2—uterine cancer	6.95e-06	0.00108	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.93e-06	0.00107	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SRD5A2—uterine cancer	6.89e-06	0.00107	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—NDUFB11—uterine cancer	6.89e-06	0.00107	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—uterine cancer	6.79e-06	0.00105	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	6.69e-06	0.00104	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—AKR1C1—uterine cancer	6.68e-06	0.00103	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—STK11—uterine cancer	6.47e-06	0.001	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—CYP19A1—uterine cancer	6.47e-06	0.001	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—RRM2—uterine cancer	6.39e-06	0.00099	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.32e-06	0.00098	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RNF43—uterine cancer	6.3e-06	0.000977	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	6.27e-06	0.000972	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RNF43—uterine cancer	6.2e-06	0.000961	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—RRM2—uterine cancer	6.2e-06	0.000961	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—DCN—uterine cancer	6.2e-06	0.000961	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	6.17e-06	0.000956	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmission across Chemical Synapses—HRAS—uterine cancer	6.08e-06	0.000942	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—CCL2—uterine cancer	6.04e-06	0.000936	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—DCN—uterine cancer	6.02e-06	0.000933	CbGpPWpGaD
Diphenhydramine—HRH1—G alpha (q) signalling events—PIK3CA—uterine cancer	6.01e-06	0.000931	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—RRM2—uterine cancer	5.95e-06	0.000922	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—CCL2—uterine cancer	5.94e-06	0.000921	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SRD5A2—uterine cancer	5.89e-06	0.000913	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NDUFB11—uterine cancer	5.89e-06	0.000913	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—uterine cancer	5.85e-06	0.000906	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CYP11A1—uterine cancer	5.84e-06	0.000905	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—DCN—uterine cancer	5.78e-06	0.000895	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—INHBA—uterine cancer	5.77e-06	0.000894	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.72e-06	0.000886	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—POLD1—uterine cancer	5.67e-06	0.000879	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—INHBA—uterine cancer	5.67e-06	0.000879	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CYP11A1—uterine cancer	5.67e-06	0.000879	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmission across Chemical Synapses—HRAS—uterine cancer	5.66e-06	0.000878	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—AKR1C3—uterine cancer	5.52e-06	0.000855	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—STAR—uterine cancer	5.46e-06	0.000847	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AKR1B1—uterine cancer	5.46e-06	0.000847	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CYP11A1—uterine cancer	5.44e-06	0.000844	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.4e-06	0.000837	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.4e-06	0.000837	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—uterine cancer	5.37e-06	0.000832	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—AKR1C3—uterine cancer	5.35e-06	0.00083	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AKR1C1—uterine cancer	5.31e-06	0.000822	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKR1C1—uterine cancer	5.19e-06	0.000805	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—AKR1C3—uterine cancer	5.14e-06	0.000797	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKR1C1—uterine cancer	5.11e-06	0.000792	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—STAR—uterine cancer	5.03e-06	0.000779	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AKR1B1—uterine cancer	5.03e-06	0.000779	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AKR1B1—uterine cancer	4.98e-06	0.000772	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—STAR—uterine cancer	4.98e-06	0.000772	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—uterine cancer	4.97e-06	0.00077	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.92e-06	0.000763	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—MTHFR—uterine cancer	4.86e-06	0.000754	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—CXCL8—uterine cancer	4.77e-06	0.00074	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—RRM2—uterine cancer	4.73e-06	0.000733	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—CXCL8—uterine cancer	4.7e-06	0.000728	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—HRAS—uterine cancer	4.66e-06	0.000722	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—DCN—uterine cancer	4.59e-06	0.000712	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—HRAS—uterine cancer	4.34e-06	0.000673	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CYP11A1—uterine cancer	4.33e-06	0.00067	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CYP19A1—uterine cancer	4.3e-06	0.000666	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—STK11—uterine cancer	4.3e-06	0.000666	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—POLD1—uterine cancer	4.29e-06	0.000664	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AKR1B1—uterine cancer	4.26e-06	0.00066	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—STAR—uterine cancer	4.26e-06	0.00066	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.21e-06	0.000652	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—STK11—uterine cancer	4.17e-06	0.000646	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CYP19A1—uterine cancer	4.17e-06	0.000646	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AKR1C3—uterine cancer	4.09e-06	0.000633	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AKR1C1—uterine cancer	4.01e-06	0.000621	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CYP19A1—uterine cancer	4.01e-06	0.000621	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—STK11—uterine cancer	4.01e-06	0.000621	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKR1C3—uterine cancer	4e-06	0.000619	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—POLD1—uterine cancer	3.94e-06	0.000611	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKR1C3—uterine cancer	3.93e-06	0.000609	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.92e-06	0.000607	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—POLD1—uterine cancer	3.91e-06	0.000606	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PGR—uterine cancer	3.89e-06	0.000604	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PGR—uterine cancer	3.83e-06	0.000594	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.73e-06	0.000579	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—YWHAE—uterine cancer	3.72e-06	0.000576	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AKR1C1—uterine cancer	3.69e-06	0.000572	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AKR1C1—uterine cancer	3.66e-06	0.000567	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—YWHAE—uterine cancer	3.66e-06	0.000567	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—RRM2—uterine cancer	3.57e-06	0.000554	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FBXW7—uterine cancer	3.56e-06	0.000552	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FBXW7—uterine cancer	3.5e-06	0.000543	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—DCN—uterine cancer	3.47e-06	0.000538	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—POLD1—uterine cancer	3.34e-06	0.000518	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—RRM2—uterine cancer	3.29e-06	0.000509	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP11A1—uterine cancer	3.27e-06	0.000507	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—RRM2—uterine cancer	3.26e-06	0.000505	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—MTHFR—uterine cancer	3.23e-06	0.0005	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—DCN—uterine cancer	3.19e-06	0.000495	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—STK11—uterine cancer	3.18e-06	0.000493	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CYP19A1—uterine cancer	3.18e-06	0.000493	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—DCN—uterine cancer	3.16e-06	0.00049	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—MTHFR—uterine cancer	3.13e-06	0.000486	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AKR1C1—uterine cancer	3.12e-06	0.000484	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—STK11—uterine cancer	3.11e-06	0.000483	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CCL2—uterine cancer	3.1e-06	0.00048	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AKR1C3—uterine cancer	3.09e-06	0.000478	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—STK11—uterine cancer	3.06e-06	0.000475	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CCL2—uterine cancer	3.05e-06	0.000473	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—MTHFR—uterine cancer	3.01e-06	0.000466	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP11A1—uterine cancer	3.01e-06	0.000466	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP11A1—uterine cancer	2.98e-06	0.000462	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SOCS3—uterine cancer	2.92e-06	0.000452	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SOCS3—uterine cancer	2.87e-06	0.000445	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AKR1C3—uterine cancer	2.84e-06	0.00044	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AKR1C3—uterine cancer	2.81e-06	0.000436	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDKN2B—uterine cancer	2.79e-06	0.000433	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—RRM2—uterine cancer	2.79e-06	0.000432	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.76e-06	0.000428	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDKN2B—uterine cancer	2.75e-06	0.000426	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IGF1R—uterine cancer	2.71e-06	0.00042	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PTEN—uterine cancer	2.71e-06	0.000419	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—DCN—uterine cancer	2.7e-06	0.000419	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CXCL8—uterine cancer	2.7e-06	0.000418	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IGF1R—uterine cancer	2.67e-06	0.000413	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CXCL8—uterine cancer	2.65e-06	0.000411	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—EP300—uterine cancer	2.58e-06	0.0004	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SMAD3—uterine cancer	2.55e-06	0.000395	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP11A1—uterine cancer	2.55e-06	0.000395	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SMAD3—uterine cancer	2.51e-06	0.000389	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CXCL8—uterine cancer	2.45e-06	0.00038	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FGFR2—uterine cancer	2.43e-06	0.000377	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CXCL8—uterine cancer	2.41e-06	0.000374	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AKR1C3—uterine cancer	2.41e-06	0.000373	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—STK11—uterine cancer	2.41e-06	0.000373	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP19A1—uterine cancer	2.41e-06	0.000373	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—MTHFR—uterine cancer	2.39e-06	0.000371	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FGFR2—uterine cancer	2.39e-06	0.000371	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.26e-06	0.00035	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP19A1—uterine cancer	2.21e-06	0.000343	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—STK11—uterine cancer	2.21e-06	0.000343	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—STK11—uterine cancer	2.19e-06	0.00034	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP19A1—uterine cancer	2.19e-06	0.00034	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.15e-06	0.000334	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ESR1—uterine cancer	2.08e-06	0.000322	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.06e-06	0.000319	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ESR1—uterine cancer	2.05e-06	0.000317	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—NRAS—uterine cancer	1.97e-06	0.000305	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.96e-06	0.000304	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—NRAS—uterine cancer	1.93e-06	0.0003	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PIK3CA—uterine cancer	1.91e-06	0.000296	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—STK11—uterine cancer	1.87e-06	0.00029	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP19A1—uterine cancer	1.87e-06	0.00029	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCL2—uterine cancer	1.83e-06	0.000284	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—MTHFR—uterine cancer	1.81e-06	0.00028	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCL2—uterine cancer	1.8e-06	0.000279	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTEN—uterine cancer	1.8e-06	0.000278	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.76e-06	0.000273	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTEN—uterine cancer	1.74e-06	0.00027	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—EP300—uterine cancer	1.71e-06	0.000265	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PIK3CA—uterine cancer	1.71e-06	0.000265	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—KRAS—uterine cancer	1.69e-06	0.000262	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PIK3CA—uterine cancer	1.68e-06	0.000261	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.68e-06	0.00026	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTEN—uterine cancer	1.67e-06	0.000259	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—KRAS—uterine cancer	1.66e-06	0.000258	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—EP300—uterine cancer	1.66e-06	0.000258	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—MTHFR—uterine cancer	1.66e-06	0.000258	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—MTHFR—uterine cancer	1.65e-06	0.000255	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—EP300—uterine cancer	1.6e-06	0.000247	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.59e-06	0.000247	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—AKT1—uterine cancer	1.56e-06	0.000242	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CA—uterine cancer	1.55e-06	0.000241	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CA—uterine cancer	1.53e-06	0.000237	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ERBB2—uterine cancer	1.53e-06	0.000237	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ERBB2—uterine cancer	1.5e-06	0.000233	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.45e-06	0.000225	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CXCL8—uterine cancer	1.45e-06	0.000224	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—HRAS—uterine cancer	1.44e-06	0.000223	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CXCL8—uterine cancer	1.42e-06	0.000221	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—HRAS—uterine cancer	1.42e-06	0.000219	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDKN1B—uterine cancer	1.41e-06	0.000219	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—MTHFR—uterine cancer	1.41e-06	0.000218	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—AKT1—uterine cancer	1.4e-06	0.000217	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDKN1B—uterine cancer	1.39e-06	0.000216	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—AKT1—uterine cancer	1.38e-06	0.000213	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CTNNB1—uterine cancer	1.34e-06	0.000207	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTEN—uterine cancer	1.33e-06	0.000206	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CTNNB1—uterine cancer	1.31e-06	0.000204	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTEN—uterine cancer	1.3e-06	0.000202	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTEN—uterine cancer	1.28e-06	0.000198	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—AKT1—uterine cancer	1.27e-06	0.000197	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—EP300—uterine cancer	1.27e-06	0.000197	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CA—uterine cancer	1.27e-06	0.000196	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—AKT1—uterine cancer	1.25e-06	0.000194	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EP300—uterine cancer	1.24e-06	0.000192	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.24e-06	0.000192	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CA—uterine cancer	1.23e-06	0.000191	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EP300—uterine cancer	1.22e-06	0.000189	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CA—uterine cancer	1.18e-06	0.000183	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—VEGFA—uterine cancer	1.18e-06	0.000182	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NRAS—uterine cancer	1.16e-06	0.00018	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—VEGFA—uterine cancer	1.16e-06	0.000179	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NRAS—uterine cancer	1.14e-06	0.000177	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—AKT1—uterine cancer	1.04e-06	0.00016	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTEN—uterine cancer	1.01e-06	0.000156	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—AKT1—uterine cancer	1.01e-06	0.000156	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KRAS—uterine cancer	9.99e-07	0.000155	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KRAS—uterine cancer	9.83e-07	0.000152	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—AKT1—uterine cancer	9.65e-07	0.00015	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—EP300—uterine cancer	9.59e-07	0.000149	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CA—uterine cancer	9.39e-07	0.000145	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTEN—uterine cancer	9.25e-07	0.000143	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CA—uterine cancer	9.18e-07	0.000142	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTEN—uterine cancer	9.17e-07	0.000142	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CA—uterine cancer	9.03e-07	0.00014	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TP53—uterine cancer	8.88e-07	0.000138	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—EP300—uterine cancer	8.82e-07	0.000137	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—EP300—uterine cancer	8.74e-07	0.000135	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TP53—uterine cancer	8.74e-07	0.000135	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HRAS—uterine cancer	8.5e-07	0.000132	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HRAS—uterine cancer	8.36e-07	0.00013	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTEN—uterine cancer	7.83e-07	0.000121	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AKT1—uterine cancer	7.67e-07	0.000119	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKT1—uterine cancer	7.5e-07	0.000116	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—EP300—uterine cancer	7.47e-07	0.000116	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKT1—uterine cancer	7.38e-07	0.000114	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CA—uterine cancer	7.09e-07	0.00011	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CA—uterine cancer	6.52e-07	0.000101	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CA—uterine cancer	6.47e-07	0.0001	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AKT1—uterine cancer	5.79e-07	8.98e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CA—uterine cancer	5.53e-07	8.57e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AKT1—uterine cancer	5.33e-07	8.26e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AKT1—uterine cancer	5.28e-07	8.19e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AKT1—uterine cancer	4.51e-07	7e-05	CbGpPWpGaD
